Global Drospirenone and Ethinylestradiol Tablets Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Drospirenone and Ethinylestradiol Tablets Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Drospirenone and Ethinylestradiol Tablets by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Drospirenone and Ethinylestradiol Tablets by Country/Region, 2017, 2022 & 2028

2.2 Drospirenone and Ethinylestradiol Tablets Segment by Type

2.2.1 With 30 μg Ethinylestradiol

2.2.2 With 20 μg Ethinylestradiol

2.3 Drospirenone and Ethinylestradiol Tablets Sales by Type

2.3.1 Global Drospirenone and Ethinylestradiol Tablets Sales Market Share by Type (2017-2022)

2.3.2 Global Drospirenone and Ethinylestradiol Tablets Revenue and Market Share by Type (2017-2022)

2.3.3 Global Drospirenone and Ethinylestradiol Tablets Sale Price by Type (2017-2022)

2.4 Drospirenone and Ethinylestradiol Tablets Segment by Application

2.4.1 Birth Control

2.4.2 Moderate Acne

2.4.3 Premenstrual Syndrome (PMS)

2.4.4 Premenstrual Dysphoric Disorder (PMDD)

2.4.5 Dysmenorrhea

2.5 Drospirenone and Ethinylestradiol Tablets Sales by Application

2.5.1 Global Drospirenone and Ethinylestradiol Tablets Sale Market Share by Application (2017-2022)

2.5.2 Global Drospirenone and Ethinylestradiol Tablets Revenue and Market Share by Application (2017-2022)

2.5.3 Global Drospirenone and Ethinylestradiol Tablets Sale Price by Application (2017-2022)

3 Global Drospirenone and Ethinylestradiol Tablets by Company

3.1 Global Drospirenone and Ethinylestradiol Tablets Breakdown Data by Company

3.1.1 Global Drospirenone and Ethinylestradiol Tablets Annual Sales by Company (2020-2022)

3.1.2 Global Drospirenone and Ethinylestradiol Tablets Sales Market Share by Company (2020-2022)

3.2 Global Drospirenone and Ethinylestradiol Tablets Annual Revenue by Company (2020-2022)

3.2.1 Global Drospirenone and Ethinylestradiol Tablets Revenue by Company (2020-2022)

3.2.2 Global Drospirenone and Ethinylestradiol Tablets Revenue Market Share by Company (2020-2022)

3.3 Global Drospirenone and Ethinylestradiol Tablets Sale Price by Company

3.4 Key Manufacturers Drospirenone and Ethinylestradiol Tablets Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Drospirenone and Ethinylestradiol Tablets Product Location Distribution

3.4.2 Players Drospirenone and Ethinylestradiol Tablets Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Drospirenone and Ethinylestradiol Tablets by Geographic Region

4.1 World Historic Drospirenone and Ethinylestradiol Tablets Market Size by Geographic Region (2017-2022)

4.1.1 Global Drospirenone and Ethinylestradiol Tablets Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Drospirenone and Ethinylestradiol Tablets Annual Revenue by Geographic Region

4.2 World Historic Drospirenone and Ethinylestradiol Tablets Market Size by Country/Region (2017-2022)

4.2.1 Global Drospirenone and Ethinylestradiol Tablets Annual Sales by Country/Region (2017-2022)

4.2.2 Global Drospirenone and Ethinylestradiol Tablets Annual Revenue by Country/Region

4.3 Americas Drospirenone and Ethinylestradiol Tablets Sales Growth

4.4 APAC Drospirenone and Ethinylestradiol Tablets Sales Growth

4.5 Europe Drospirenone and Ethinylestradiol Tablets Sales Growth

4.6 Middle East & Africa Drospirenone and Ethinylestradiol Tablets Sales Growth

5 Americas

5.1 Americas Drospirenone and Ethinylestradiol Tablets Sales by Country

5.1.1 Americas Drospirenone and Ethinylestradiol Tablets Sales by Country (2017-2022)

5.1.2 Americas Drospirenone and Ethinylestradiol Tablets Revenue by Country (2017-2022)

5.2 Americas Drospirenone and Ethinylestradiol Tablets Sales by Type

5.3 Americas Drospirenone and Ethinylestradiol Tablets Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Drospirenone and Ethinylestradiol Tablets Sales by Region

6.1.1 APAC Drospirenone and Ethinylestradiol Tablets Sales by Region (2017-2022)

6.1.2 APAC Drospirenone and Ethinylestradiol Tablets Revenue by Region (2017-2022)

6.2 APAC Drospirenone and Ethinylestradiol Tablets Sales by Type

6.3 APAC Drospirenone and Ethinylestradiol Tablets Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Drospirenone and Ethinylestradiol Tablets by Country

7.1.1 Europe Drospirenone and Ethinylestradiol Tablets Sales by Country (2017-2022)

7.1.2 Europe Drospirenone and Ethinylestradiol Tablets Revenue by Country (2017-2022)

7.2 Europe Drospirenone and Ethinylestradiol Tablets Sales by Type

7.3 Europe Drospirenone and Ethinylestradiol Tablets Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Drospirenone and Ethinylestradiol Tablets by Country

8.1.1 Middle East & Africa Drospirenone and Ethinylestradiol Tablets Sales by Country (2017-2022)

8.1.2 Middle East & Africa Drospirenone and Ethinylestradiol Tablets Revenue by Country (2017-2022)

8.2 Middle East & Africa Drospirenone and Ethinylestradiol Tablets Sales by Type

8.3 Middle East & Africa Drospirenone and Ethinylestradiol Tablets Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Drospirenone and Ethinylestradiol Tablets

10.3 Manufacturing Process Analysis of Drospirenone and Ethinylestradiol Tablets

10.4 Industry Chain Structure of Drospirenone and Ethinylestradiol Tablets

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Drospirenone and Ethinylestradiol Tablets Distributors

11.3 Drospirenone and Ethinylestradiol Tablets Customer

12 World Forecast Review for Drospirenone and Ethinylestradiol Tablets by Geographic Region

12.1 Global Drospirenone and Ethinylestradiol Tablets Market Size Forecast by Region

12.1.1 Global Drospirenone and Ethinylestradiol Tablets Forecast by Region (2023-2028)

12.1.2 Global Drospirenone and Ethinylestradiol Tablets Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Drospirenone and Ethinylestradiol Tablets Forecast by Type

12.7 Global Drospirenone and Ethinylestradiol Tablets Forecast by Application

13 Key Players Analysis

13.1 Camber Pharmaceuticals

13.1.1 Camber Pharmaceuticals Company Information

13.1.2 Camber Pharmaceuticals Drospirenone and Ethinylestradiol Tablets Product Offered

13.1.3 Camber Pharmaceuticals Drospirenone and Ethinylestradiol Tablets Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Camber Pharmaceuticals Main Business Overview

13.1.5 Camber Pharmaceuticals Latest Developments

13.2 Aurobindo Pharma

13.2.1 Aurobindo Pharma Company Information

13.2.2 Aurobindo Pharma Drospirenone and Ethinylestradiol Tablets Product Offered

13.2.3 Aurobindo Pharma Drospirenone and Ethinylestradiol Tablets Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Aurobindo Pharma Main Business Overview

13.2.5 Aurobindo Pharma Latest Developments

13.3 Teva Generics

13.3.1 Teva Generics Company Information

13.3.2 Teva Generics Drospirenone and Ethinylestradiol Tablets Product Offered

13.3.3 Teva Generics Drospirenone and Ethinylestradiol Tablets Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Teva Generics Main Business Overview

13.3.5 Teva Generics Latest Developments

13.4 Glenmark Pharmaceuticals

13.4.1 Glenmark Pharmaceuticals Company Information

13.4.2 Glenmark Pharmaceuticals Drospirenone and Ethinylestradiol Tablets Product Offered

13.4.3 Glenmark Pharmaceuticals Drospirenone and Ethinylestradiol Tablets Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Glenmark Pharmaceuticals Main Business Overview

13.4.5 Glenmark Pharmaceuticals Latest Developments

13.5 Xiromed

13.5.1 Xiromed Company Information

13.5.2 Xiromed Drospirenone and Ethinylestradiol Tablets Product Offered

13.5.3 Xiromed Drospirenone and Ethinylestradiol Tablets Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Xiromed Main Business Overview

13.5.5 Xiromed Latest Developments

13.6 Wellona Pharma

13.6.1 Wellona Pharma Company Information

13.6.2 Wellona Pharma Drospirenone and Ethinylestradiol Tablets Product Offered

13.6.3 Wellona Pharma Drospirenone and Ethinylestradiol Tablets Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Wellona Pharma Main Business Overview

13.6.5 Wellona Pharma Latest Developments

13.7 Barr Pharmaceuticals, Inc.

13.7.1 Barr Pharmaceuticals, Inc. Company Information

13.7.2 Barr Pharmaceuticals, Inc. Drospirenone and Ethinylestradiol Tablets Product Offered

13.7.3 Barr Pharmaceuticals, Inc. Drospirenone and Ethinylestradiol Tablets Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Barr Pharmaceuticals, Inc. Main Business Overview

13.7.5 Barr Pharmaceuticals, Inc. Latest Developments

13.8 Hetero Drugs

13.8.1 Hetero Drugs Company Information

13.8.2 Hetero Drugs Drospirenone and Ethinylestradiol Tablets Product Offered

13.8.3 Hetero Drugs Drospirenone and Ethinylestradiol Tablets Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Hetero Drugs Main Business Overview

13.8.5 Hetero Drugs Latest Developments

13.9 MYLAN LABS LTD.

13.9.1 MYLAN LABS LTD. Company Information

13.9.2 MYLAN LABS LTD. Drospirenone and Ethinylestradiol Tablets Product Offered

13.9.3 MYLAN LABS LTD. Drospirenone and Ethinylestradiol Tablets Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 MYLAN LABS LTD. Main Business Overview

13.9.5 MYLAN LABS LTD. Latest Developments

13.10 Bayer Weimar GmbH und Co. KG

13.10.1 Bayer Weimar GmbH und Co. KG Company Information

13.10.2 Bayer Weimar GmbH und Co. KG Drospirenone and Ethinylestradiol Tablets Product Offered

13.10.3 Bayer Weimar GmbH und Co. KG Drospirenone and Ethinylestradiol Tablets Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Bayer Weimar GmbH und Co. KG Main Business Overview

13.10.5 Bayer Weimar GmbH und Co. KG Latest Developments

14 Research Findings and Conclusion

Table 1. Drospirenone and Ethinylestradiol Tablets Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Drospirenone and Ethinylestradiol Tablets Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of With 30 μg Ethinylestradiol

Table 4. Major Players of With 20 μg Ethinylestradiol

Table 5. Global Drospirenone and Ethinylestradiol Tablets Sales by Type (2017-2022) & (K Units)

Table 6. Global Drospirenone and Ethinylestradiol Tablets Sales Market Share by Type (2017-2022)

Table 7. Global Drospirenone and Ethinylestradiol Tablets Revenue by Type (2017-2022) & ($ million)

Table 8. Global Drospirenone and Ethinylestradiol Tablets Revenue Market Share by Type (2017-2022)

Table 9. Global Drospirenone and Ethinylestradiol Tablets Sale Price by Type (2017-2022) & (US$/Unit)

Table 10. Global Drospirenone and Ethinylestradiol Tablets Sales by Application (2017-2022) & (K Units)

Table 11. Global Drospirenone and Ethinylestradiol Tablets Sales Market Share by Application (2017-2022)

Table 12. Global Drospirenone and Ethinylestradiol Tablets Revenue by Application (2017-2022)

Table 13. Global Drospirenone and Ethinylestradiol Tablets Revenue Market Share by Application (2017-2022)

Table 14. Global Drospirenone and Ethinylestradiol Tablets Sale Price by Application (2017-2022) & (US$/Unit)

Table 15. Global Drospirenone and Ethinylestradiol Tablets Sales by Company (2020-2022) & (K Units)

Table 16. Global Drospirenone and Ethinylestradiol Tablets Sales Market Share by Company (2020-2022)

Table 17. Global Drospirenone and Ethinylestradiol Tablets Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Drospirenone and Ethinylestradiol Tablets Revenue Market Share by Company (2020-2022)

Table 19. Global Drospirenone and Ethinylestradiol Tablets Sale Price by Company (2020-2022) & (US$/Unit)

Table 20. Key Manufacturers Drospirenone and Ethinylestradiol Tablets Producing Area Distribution and Sales Area

Table 21. Players Drospirenone and Ethinylestradiol Tablets Products Offered

Table 22. Drospirenone and Ethinylestradiol Tablets Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Drospirenone and Ethinylestradiol Tablets Sales by Geographic Region (2017-2022) & (K Units)

Table 26. Global Drospirenone and Ethinylestradiol Tablets Sales Market Share Geographic Region (2017-2022)

Table 27. Global Drospirenone and Ethinylestradiol Tablets Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Drospirenone and Ethinylestradiol Tablets Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Drospirenone and Ethinylestradiol Tablets Sales by Country/Region (2017-2022) & (K Units)

Table 30. Global Drospirenone and Ethinylestradiol Tablets Sales Market Share by Country/Region (2017-2022)

Table 31. Global Drospirenone and Ethinylestradiol Tablets Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Drospirenone and Ethinylestradiol Tablets Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Drospirenone and Ethinylestradiol Tablets Sales by Country (2017-2022) & (K Units)

Table 34. Americas Drospirenone and Ethinylestradiol Tablets Sales Market Share by Country (2017-2022)

Table 35. Americas Drospirenone and Ethinylestradiol Tablets Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Drospirenone and Ethinylestradiol Tablets Revenue Market Share by Country (2017-2022)

Table 37. Americas Drospirenone and Ethinylestradiol Tablets Sales by Type (2017-2022) & (K Units)

Table 38. Americas Drospirenone and Ethinylestradiol Tablets Sales Market Share by Type (2017-2022)

Table 39. Americas Drospirenone and Ethinylestradiol Tablets Sales by Application (2017-2022) & (K Units)

Table 40. Americas Drospirenone and Ethinylestradiol Tablets Sales Market Share by Application (2017-2022)

Table 41. APAC Drospirenone and Ethinylestradiol Tablets Sales by Region (2017-2022) & (K Units)

Table 42. APAC Drospirenone and Ethinylestradiol Tablets Sales Market Share by Region (2017-2022)

Table 43. APAC Drospirenone and Ethinylestradiol Tablets Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Drospirenone and Ethinylestradiol Tablets Revenue Market Share by Region (2017-2022)

Table 45. APAC Drospirenone and Ethinylestradiol Tablets Sales by Type (2017-2022) & (K Units)

Table 46. APAC Drospirenone and Ethinylestradiol Tablets Sales Market Share by Type (2017-2022)

Table 47. APAC Drospirenone and Ethinylestradiol Tablets Sales by Application (2017-2022) & (K Units)

Table 48. APAC Drospirenone and Ethinylestradiol Tablets Sales Market Share by Application (2017-2022)

Table 49. Europe Drospirenone and Ethinylestradiol Tablets Sales by Country (2017-2022) & (K Units)

Table 50. Europe Drospirenone and Ethinylestradiol Tablets Sales Market Share by Country (2017-2022)

Table 51. Europe Drospirenone and Ethinylestradiol Tablets Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Drospirenone and Ethinylestradiol Tablets Revenue Market Share by Country (2017-2022)

Table 53. Europe Drospirenone and Ethinylestradiol Tablets Sales by Type (2017-2022) & (K Units)

Table 54. Europe Drospirenone and Ethinylestradiol Tablets Sales Market Share by Type (2017-2022)

Table 55. Europe Drospirenone and Ethinylestradiol Tablets Sales by Application (2017-2022) & (K Units)

Table 56. Europe Drospirenone and Ethinylestradiol Tablets Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Drospirenone and Ethinylestradiol Tablets Sales by Country (2017-2022) & (K Units)

Table 58. Middle East & Africa Drospirenone and Ethinylestradiol Tablets Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Drospirenone and Ethinylestradiol Tablets Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Drospirenone and Ethinylestradiol Tablets Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Drospirenone and Ethinylestradiol Tablets Sales by Type (2017-2022) & (K Units)

Table 62. Middle East & Africa Drospirenone and Ethinylestradiol Tablets Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Drospirenone and Ethinylestradiol Tablets Sales by Application (2017-2022) & (K Units)

Table 64. Middle East & Africa Drospirenone and Ethinylestradiol Tablets Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Drospirenone and Ethinylestradiol Tablets

Table 66. Key Market Challenges & Risks of Drospirenone and Ethinylestradiol Tablets

Table 67. Key Industry Trends of Drospirenone and Ethinylestradiol Tablets

Table 68. Drospirenone and Ethinylestradiol Tablets Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Drospirenone and Ethinylestradiol Tablets Distributors List

Table 71. Drospirenone and Ethinylestradiol Tablets Customer List

Table 72. Global Drospirenone and Ethinylestradiol Tablets Sales Forecast by Region (2023-2028) & (K Units)

Table 73. Global Drospirenone and Ethinylestradiol Tablets Sales Market Forecast by Region

Table 74. Global Drospirenone and Ethinylestradiol Tablets Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Drospirenone and Ethinylestradiol Tablets Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Drospirenone and Ethinylestradiol Tablets Sales Forecast by Country (2023-2028) & (K Units)

Table 77. Americas Drospirenone and Ethinylestradiol Tablets Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Drospirenone and Ethinylestradiol Tablets Sales Forecast by Region (2023-2028) & (K Units)

Table 79. APAC Drospirenone and Ethinylestradiol Tablets Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Drospirenone and Ethinylestradiol Tablets Sales Forecast by Country (2023-2028) & (K Units)

Table 81. Europe Drospirenone and Ethinylestradiol Tablets Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Drospirenone and Ethinylestradiol Tablets Sales Forecast by Country (2023-2028) & (K Units)

Table 83. Middle East & Africa Drospirenone and Ethinylestradiol Tablets Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Drospirenone and Ethinylestradiol Tablets Sales Forecast by Type (2023-2028) & (K Units)

Table 85. Global Drospirenone and Ethinylestradiol Tablets Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Drospirenone and Ethinylestradiol Tablets Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Drospirenone and Ethinylestradiol Tablets Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Drospirenone and Ethinylestradiol Tablets Sales Forecast by Application (2023-2028) & (K Units)

Table 89. Global Drospirenone and Ethinylestradiol Tablets Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Drospirenone and Ethinylestradiol Tablets Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Drospirenone and Ethinylestradiol Tablets Revenue Market Share Forecast by Application (2023-2028)

Table 92. Camber Pharmaceuticals Basic Information, Drospirenone and Ethinylestradiol Tablets Manufacturing Base, Sales Area and Its Competitors

Table 93. Camber Pharmaceuticals Drospirenone and Ethinylestradiol Tablets Product Offered

Table 94. Camber Pharmaceuticals Drospirenone and Ethinylestradiol Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 95. Camber Pharmaceuticals Main Business

Table 96. Camber Pharmaceuticals Latest Developments

Table 97. Aurobindo Pharma Basic Information, Drospirenone and Ethinylestradiol Tablets Manufacturing Base, Sales Area and Its Competitors

Table 98. Aurobindo Pharma Drospirenone and Ethinylestradiol Tablets Product Offered

Table 99. Aurobindo Pharma Drospirenone and Ethinylestradiol Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 100. Aurobindo Pharma Main Business

Table 101. Aurobindo Pharma Latest Developments

Table 102. Teva Generics Basic Information, Drospirenone and Ethinylestradiol Tablets Manufacturing Base, Sales Area and Its Competitors

Table 103. Teva Generics Drospirenone and Ethinylestradiol Tablets Product Offered

Table 104. Teva Generics Drospirenone and Ethinylestradiol Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 105. Teva Generics Main Business

Table 106. Teva Generics Latest Developments

Table 107. Glenmark Pharmaceuticals Basic Information, Drospirenone and Ethinylestradiol Tablets Manufacturing Base, Sales Area and Its Competitors

Table 108. Glenmark Pharmaceuticals Drospirenone and Ethinylestradiol Tablets Product Offered

Table 109. Glenmark Pharmaceuticals Drospirenone and Ethinylestradiol Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 110. Glenmark Pharmaceuticals Main Business

Table 111. Glenmark Pharmaceuticals Latest Developments

Table 112. Xiromed Basic Information, Drospirenone and Ethinylestradiol Tablets Manufacturing Base, Sales Area and Its Competitors

Table 113. Xiromed Drospirenone and Ethinylestradiol Tablets Product Offered

Table 114. Xiromed Drospirenone and Ethinylestradiol Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 115. Xiromed Main Business

Table 116. Xiromed Latest Developments

Table 117. Wellona Pharma Basic Information, Drospirenone and Ethinylestradiol Tablets Manufacturing Base, Sales Area and Its Competitors

Table 118. Wellona Pharma Drospirenone and Ethinylestradiol Tablets Product Offered

Table 119. Wellona Pharma Drospirenone and Ethinylestradiol Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 120. Wellona Pharma Main Business

Table 121. Wellona Pharma Latest Developments

Table 122. Barr Pharmaceuticals, Inc. Basic Information, Drospirenone and Ethinylestradiol Tablets Manufacturing Base, Sales Area and Its Competitors

Table 123. Barr Pharmaceuticals, Inc. Drospirenone and Ethinylestradiol Tablets Product Offered

Table 124. Barr Pharmaceuticals, Inc. Drospirenone and Ethinylestradiol Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 125. Barr Pharmaceuticals, Inc. Main Business

Table 126. Barr Pharmaceuticals, Inc. Latest Developments

Table 127. Hetero Drugs Basic Information, Drospirenone and Ethinylestradiol Tablets Manufacturing Base, Sales Area and Its Competitors

Table 128. Hetero Drugs Drospirenone and Ethinylestradiol Tablets Product Offered

Table 129. Hetero Drugs Drospirenone and Ethinylestradiol Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 130. Hetero Drugs Main Business

Table 131. Hetero Drugs Latest Developments

Table 132. MYLAN LABS LTD. Basic Information, Drospirenone and Ethinylestradiol Tablets Manufacturing Base, Sales Area and Its Competitors

Table 133. MYLAN LABS LTD. Drospirenone and Ethinylestradiol Tablets Product Offered

Table 134. MYLAN LABS LTD. Drospirenone and Ethinylestradiol Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 135. MYLAN LABS LTD. Main Business

Table 136. MYLAN LABS LTD. Latest Developments

Table 137. Bayer Weimar GmbH und Co. KG Basic Information, Drospirenone and Ethinylestradiol Tablets Manufacturing Base, Sales Area and Its Competitors

Table 138. Bayer Weimar GmbH und Co. KG Drospirenone and Ethinylestradiol Tablets Product Offered

Table 139. Bayer Weimar GmbH und Co. KG Drospirenone and Ethinylestradiol Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 140. Bayer Weimar GmbH und Co. KG Main Business

Table 141. Bayer Weimar GmbH und Co. KG Latest Developments

List of Figures

Figure 1. Picture of Drospirenone and Ethinylestradiol Tablets

Figure 2. Drospirenone and Ethinylestradiol Tablets Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Drospirenone and Ethinylestradiol Tablets Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Drospirenone and Ethinylestradiol Tablets Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Drospirenone and Ethinylestradiol Tablets Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of With 30 μg Ethinylestradiol

Figure 10. Product Picture of With 20 μg Ethinylestradiol

Figure 11. Global Drospirenone and Ethinylestradiol Tablets Sales Market Share by Type in 2021

Figure 12. Global Drospirenone and Ethinylestradiol Tablets Revenue Market Share by Type (2017-2022)

Figure 13. Drospirenone and Ethinylestradiol Tablets Consumed in Birth Control

Figure 14. Global Drospirenone and Ethinylestradiol Tablets Market: Birth Control (2017-2022) & (K Units)

Figure 15. Drospirenone and Ethinylestradiol Tablets Consumed in Moderate Acne

Figure 16. Global Drospirenone and Ethinylestradiol Tablets Market: Moderate Acne (2017-2022) & (K Units)

Figure 17. Drospirenone and Ethinylestradiol Tablets Consumed in Premenstrual Syndrome (PMS)

Figure 18. Global Drospirenone and Ethinylestradiol Tablets Market: Premenstrual Syndrome (PMS) (2017-2022) & (K Units)

Figure 19. Drospirenone and Ethinylestradiol Tablets Consumed in Premenstrual Dysphoric Disorder (PMDD)

Figure 20. Global Drospirenone and Ethinylestradiol Tablets Market: Premenstrual Dysphoric Disorder (PMDD) (2017-2022) & (K Units)

Figure 21. Drospirenone and Ethinylestradiol Tablets Consumed in Dysmenorrhea

Figure 22. Global Drospirenone and Ethinylestradiol Tablets Market: Dysmenorrhea (2017-2022) & (K Units)

Figure 23. Global Drospirenone and Ethinylestradiol Tablets Sales Market Share by Application (2017-2022)

Figure 24. Global Drospirenone and Ethinylestradiol Tablets Revenue Market Share by Application in 2021

Figure 25. Drospirenone and Ethinylestradiol Tablets Revenue Market by Company in 2021 ($ Million)

Figure 26. Global Drospirenone and Ethinylestradiol Tablets Revenue Market Share by Company in 2021

Figure 27. Global Drospirenone and Ethinylestradiol Tablets Sales Market Share by Geographic Region (2017-2022)

Figure 28. Global Drospirenone and Ethinylestradiol Tablets Revenue Market Share by Geographic Region in 2021

Figure 29. Global Drospirenone and Ethinylestradiol Tablets Sales Market Share by Region (2017-2022)

Figure 30. Global Drospirenone and Ethinylestradiol Tablets Revenue Market Share by Country/Region in 2021

Figure 31. Americas Drospirenone and Ethinylestradiol Tablets Sales 2017-2022 (K Units)

Figure 32. Americas Drospirenone and Ethinylestradiol Tablets Revenue 2017-2022 ($ Millions)

Figure 33. APAC Drospirenone and Ethinylestradiol Tablets Sales 2017-2022 (K Units)

Figure 34. APAC Drospirenone and Ethinylestradiol Tablets Revenue 2017-2022 ($ Millions)

Figure 35. Europe Drospirenone and Ethinylestradiol Tablets Sales 2017-2022 (K Units)

Figure 36. Europe Drospirenone and Ethinylestradiol Tablets Revenue 2017-2022 ($ Millions)

Figure 37. Middle East & Africa Drospirenone and Ethinylestradiol Tablets Sales 2017-2022 (K Units)

Figure 38. Middle East & Africa Drospirenone and Ethinylestradiol Tablets Revenue 2017-2022 ($ Millions)

Figure 39. Americas Drospirenone and Ethinylestradiol Tablets Sales Market Share by Country in 2021

Figure 40. Americas Drospirenone and Ethinylestradiol Tablets Revenue Market Share by Country in 2021

Figure 41. United States Drospirenone and Ethinylestradiol Tablets Revenue Growth 2017-2022 ($ Millions)

Figure 42. Canada Drospirenone and Ethinylestradiol Tablets Revenue Growth 2017-2022 ($ Millions)

Figure 43. Mexico Drospirenone and Ethinylestradiol Tablets Revenue Growth 2017-2022 ($ Millions)

Figure 44. Brazil Drospirenone and Ethinylestradiol Tablets Revenue Growth 2017-2022 ($ Millions)

Figure 45. APAC Drospirenone and Ethinylestradiol Tablets Sales Market Share by Region in 2021

Figure 46. APAC Drospirenone and Ethinylestradiol Tablets Revenue Market Share by Regions in 2021

Figure 47. China Drospirenone and Ethinylestradiol Tablets Revenue Growth 2017-2022 ($ Millions)

Figure 48. Japan Drospirenone and Ethinylestradiol Tablets Revenue Growth 2017-2022 ($ Millions)

Figure 49. South Korea Drospirenone and Ethinylestradiol Tablets Revenue Growth 2017-2022 ($ Millions)

Figure 50. Southeast Asia Drospirenone and Ethinylestradiol Tablets Revenue Growth 2017-2022 ($ Millions)

Figure 51. India Drospirenone and Ethinylestradiol Tablets Revenue Growth 2017-2022 ($ Millions)

Figure 52. Australia Drospirenone and Ethinylestradiol Tablets Revenue Growth 2017-2022 ($ Millions)

Figure 53. Europe Drospirenone and Ethinylestradiol Tablets Sales Market Share by Country in 2021

Figure 54. Europe Drospirenone and Ethinylestradiol Tablets Revenue Market Share by Country in 2021

Figure 55. Germany Drospirenone and Ethinylestradiol Tablets Revenue Growth 2017-2022 ($ Millions)

Figure 56. France Drospirenone and Ethinylestradiol Tablets Revenue Growth 2017-2022 ($ Millions)

Figure 57. UK Drospirenone and Ethinylestradiol Tablets Revenue Growth 2017-2022 ($ Millions)

Figure 58. Italy Drospirenone and Ethinylestradiol Tablets Revenue Growth 2017-2022 ($ Millions)

Figure 59. Russia Drospirenone and Ethinylestradiol Tablets Revenue Growth 2017-2022 ($ Millions)

Figure 60. Middle East & Africa Drospirenone and Ethinylestradiol Tablets Sales Market Share by Country in 2021

Figure 61. Middle East & Africa Drospirenone and Ethinylestradiol Tablets Revenue Market Share by Country in 2021

Figure 62. Egypt Drospirenone and Ethinylestradiol Tablets Revenue Growth 2017-2022 ($ Millions)

Figure 63. South Africa Drospirenone and Ethinylestradiol Tablets Revenue Growth 2017-2022 ($ Millions)

Figure 64. Israel Drospirenone and Ethinylestradiol Tablets Revenue Growth 2017-2022 ($ Millions)

Figure 65. Turkey Drospirenone and Ethinylestradiol Tablets Revenue Growth 2017-2022 ($ Millions)

Figure 66. GCC Country Drospirenone and Ethinylestradiol Tablets Revenue Growth 2017-2022 ($ Millions)

Figure 67. Manufacturing Cost Structure Analysis of Drospirenone and Ethinylestradiol Tablets in 2021

Figure 68. Manufacturing Process Analysis of Drospirenone and Ethinylestradiol Tablets

Figure 69. Industry Chain Structure of Drospirenone and Ethinylestradiol Tablets

Figure 70. Channels of Distribution

Figure 71. Distributors Profiles